Antiinflammatory effects of Tacrolimus in a mouse model of pleurisy

Transplant Immunology

Volumn 16, Issue 2, 2006, Pages 105-111

  Pereira, Robson ^a   Santos Medeiros, Yara ^a   Fröde, Tânia Silvia ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Cytokines; Leukocytes; Mediators of inflammation; Mouse pleurisy; Tacrolimus

Indexed keywords

ADENOSINE DEAMINASE; BRADYKININ; CARRAGEENAN; CYTOKINE; DEXAMETHASONE; HISTAMINE; INTERLEUKIN 1BETA; MYELOPEROXIDASE; NITRATE; NITRIC OXIDE; NITRITE; SUBSTANCE P; TACROLIMUS; TUMOR NECROSIS FACTOR ALPHA;

ACUTE DRUG ADMINISTRATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INHIBITION; ERYTHROCYTE; EXUDATE; LEUKOCYTE; LEUKOCYTE MIGRATION; LEUKOCYTE MIGRATION INHIBITION TEST; MEDIATOR RELEASE; MOUSE; NEUTROPHIL; NONHUMAN; PLEURA FLUID; PLEURISY; PRIORITY JOURNAL;

ADENOSINE DEAMINASE; ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS; BRADYKININ; CARRAGEENAN; CELL MOVEMENT; DEXAMETHASONE; DISEASE MODELS, ANIMAL; HISTAMINE; HISTAMINE AGENTS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATION; INTERLEUKIN-1; MICE; NEUTROPHIL INFILTRATION; NITRIC OXIDE; PEROXIDASE; PLEURISY; TACROLIMUS; TUMOR NECROSIS FACTOR-ALPHA; VASODILATOR AGENTS;

EID: 33745999796     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2006.04.001     Document Type: Article

References (35)

1. Kino T., Hatanaka H., Miyata S., Inamura N., Nishiyama M., Yajima T., et al. FK506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro. J Antibiot 40 9 (1987) 1256-1265
2. De Bonis M., Reynolds L., Barros J., and Madden B.P. Tacrolimus as a rescue immunosuppressant after heart transplantation. Eur J Cardio-thorac Surg 19 5 (2001) 690-695
3. Gruessner R.W. Tacrolimus. Suggested guidelines for the use of tacrolimus in pancreas/kidney transplantation. Clin Transplant 12 3 (1998) 260-262
4. Yanik G., Levine J.E., Ratanatharathorn V., Dunn R., Ferrara J., and Hutchinson R.J. Tacrolimus (FK506) and methotrexate as prophylaxis for acute graft-versus-host disease in pediatric allogeneic stem cell transplantation. Bone Marrow Transplant 26 2 (2000) 161-167
5. Reyes J., Jain A., Mazariegos G., Kashyap R., Green M., Iurlana K., et al. Long-term results after conversion from cyclosporine to tacrolimus in pediatric liver transplantation for acute and chronic rejection. Transplantation 69 12 (2000) 2573-2580
6. Shapiro R. Tacrolimus in pediatric renal transplantation: a review. Pediatr Transplant 2 4 (1998) 270-276
7. Schachner L.A., Lamerson C., Sheehan M.P., Boguniewicz M., Mosser J., and Raimer S. Tacrolimus ointment 0.03% is safe and effective for the treatment of mild to moderate atopic dermatitis in pediatric patients: results from a randomized, double-blind, vehicle-controlled study. Pediatrics 116 3 (2005) 334-342
8. Magari K., Miyata S., Ohkubo Y., and Mutoh S. Inflammatory cytokine levels in paw tissues during development of rat collagen-induced arthritis: effect of FK506, an inhibitor of T cell activation. Inflamm Res 53 9 (2004) 469-474
9. Ho S., Clipstone N., Timmermann L., Northrop J., Graef I., Fiorentino D., et al. The mechanism of action of cyclosporine A and FK506. Clin Immunol Immunopathol 80 3Pt 2 (1996) S40-S45
10. Hutchinson I.V., Bagnall W., Bryce P., Pufong B., Geraghty P., and Brogan I. Differences in the mode of action of cyclosporine and FK 506. Transplant Proc 30 4 (1998) 959-960
11. Fung J.J. Tacrolimus and transplantation: a decade in review. Transplantation 77 9 Suppl (2004) S41-S43
12. COBEA: Colégio Brasileiro de experimentação Animal. www.cobea.org.br.
13. Saleh T.S.F., Calixto J.B., and Medeiros Y.S. Anti-inflammatory effects of theophylline, cromolyn and salbutamol in a murine model of pleurisy. Br J Pharmacol 118 3 (1996) 811-819
14. Saleh T.S.F., Calixto J.B., and Medeiros Y.S. Proinflammatory effects induced by bradykinin in a murine model of pleurisy. Eur J Pharmacol 331 1 (1997) 43-52
15. DaCunha F.M., Frode T.S., Mendes G.L., Malheiros A., Cechinel Filho V., Yunes R.A., et al. Additional al evidence for the anti-inflammatory and anti-allergic properties of the sesquiterpene polygodial. Life Sci 70 2 (2001) 159-169
16. Frode-Saleh T.S., Calixto J.B., and Medeiros Y.S. Analysis of the anti-inflammatory response induced by substance P in the mouse pleural cavity. Peptides 20 2 (1999) 259-265
17. 2 receptors in bradykinin-induced rat paw oedema. Br J Pharmacol 114 5 (1995) 1005-1013
18. Di Rosa M., Lalenti A., Ianaro A., and Sautebin L. Interaction between nitric oxide and cyclooxygenase pathways. Prostaglandins Leukot Essent Fat Acids 54 4 (1996) 229-238
19. Saleh T.S.F., Calixto J.B., and Medeiros Y.S. Effects of anti-inflammatory drugs upon nitrate and myeloperoxidase levels in the mouse pleurisy induced by carrageenan. Peptides 20 8 (1999) 949-956
20. Rao T.S., Currie J.L., Shaffer A.L., and Isakson P.C. Comparative evaluation of arachidonic acid (AA)- and tetradecanoylphorbol acetate (TPA)-induced dermal inflammation. Inflammation 17 6 (1993) 723-741
21. Giusti G., and Galanti B. Adenosine-deaminase: colorimetric method. In: Bergmeyer H.U. (Ed). Methods of enzymatic analyses (1984), Verlac Chemie, New York 315
22. Frode T.S., and Medeiros Y.S. Myeloperoxidase and adenosine-deaminase levels in the pleural fluid leakage induced by carrageenan in the mouse model of pleurisy. Mediat Inflamm 10 4 (2001) 223-227
23. Bornhovd E.C., Burgdorf W.H., and Wollenberg A. Immunomodulatory macrolactams for topical treatment of inflammatory skin diseases. Curr Opin Invest Drugs 3 5 (2002) 708-712
24. Barnes P.J., and Karin M. Nuclear factor-Kappa B: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336 15 (1997) 1066-1071
25. Barnes P.J., and Adcock I.M. Transcription factors and asthma. Eur J Respir 12 1 (1998) 221-234
26. Hart L., Lim S., Adcock I., Barnes P.J., and Chung K.F. Effects of inhaled corticosteroid therapy on expression and DNA-binding activity of nuclear factor Kappa B in asthma. Am J Respir Crit Care Med 161 1 (2000) 224-231
27. Barnes P.J., and Adcock I.M. How do corticosteroids work in asthma?. Rev Ann Intern Med 139 (2003) 359-370
28. Fröde T.S., Souza G.E., and Calixto J.B. The modulatory role played by TNF alpha and IL-1 beta in the inflammatory responses induced by carrageenan in the mouse model of pleurisy. Cytokine 13 3 (2001) 162-168
29. Subauste M.C., Choi D.C., and Proud D. Transient exposure of human bronchial epithelial cell to cytokines leads to persistent increased expression of ICAM-1. Inflammation 25 6 (2001) 373-380
30. Zhang W.J., and Frei B. α-Lipoic acid inhibits TNF-α-induced NF-κB activation and adhesion molecule expression in human aortic endothelial cells. FASEB J 15 13 (2001) 2423-2432
31. Butler L.M., Rainger G.D., Rahman M., and Nash G.B. Prolonged culture of endothelial cells and deposition of basement membrane modify the recruitment of neutrophils. Exp Cell Res 310 1 (2005) 22-32
32. Dalmarco E.M., Frode T.S., and Medeiros Y.S. Effects of methotrexate upon inflammatory parameters induced by carrageenan in the mouse model of pleurisy. Mediat Inflamm 11 5 (2002) 299-306
33. Dalmarco E.M., Frode T.S., and Medeiros Y.S. Additional evidence of acute anti-inflammatory effects of cyclosporin A in a murine model of pleurisy. Transplant Immunol 12 2 (2004) 151-157
34. Lee R.K., Knapp S., and Wurtman R.J. Prostaglandin E2 stimulates amyloid precursor protein gene expression: inhibition by immunosuppressants. J Neurosci 19 3 (1999) 940-947
35. Hultsch T., Brand P., Lohmann S., Saloga J., Kincaid R.L., and Knop J. Direct evidence that FK506 inhibition of FcepsilonRI-mediated exocytosis from RBL mast cells involves calcineurin. Arch Dermatol Res 290 5 (1998) 258-263